Elizabeth Half

3.5k total citations
49 papers, 2.2k citations indexed

About

Elizabeth Half is a scholar working on Oncology, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, Elizabeth Half has authored 49 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 20 papers in Pathology and Forensic Medicine and 15 papers in Surgery. Recurrent topics in Elizabeth Half's work include Genetic factors in colorectal cancer (20 papers), Colorectal Cancer Screening and Detection (20 papers) and Inflammatory mediators and NSAID effects (10 papers). Elizabeth Half is often cited by papers focused on Genetic factors in colorectal cancer (20 papers), Colorectal Cancer Screening and Detection (20 papers) and Inflammatory mediators and NSAID effects (10 papers). Elizabeth Half collaborates with scholars based in Israel, United States and Canada. Elizabeth Half's co-authors include Frank A. Sinicrope, Dani Bercovich, Paul Rozen, Xi Tang, Nadir Arber, M. Tien Kuo, Fred M. Konikoff, Karin Gwyn, Ayşegül A. Şahin and Yunjie Sun and has published in prestigious journals such as Gastroenterology, Cancer and Gut.

In The Last Decade

Elizabeth Half

47 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elizabeth Half Israel 19 800 607 519 510 502 49 2.2k
Gideon Steinbach United States 17 705 0.9× 340 0.6× 603 1.2× 339 0.7× 321 0.6× 31 1.8k
Roberto Mazzanti Italy 27 820 1.0× 820 1.4× 390 0.8× 457 0.9× 195 0.4× 77 2.8k
Russell F. Jacoby United States 17 734 0.9× 703 1.2× 580 1.1× 346 0.7× 643 1.3× 28 2.0k
Lee J. Hixson United States 21 902 1.1× 254 0.4× 516 1.0× 651 1.3× 339 0.7× 34 2.0k
Graham P. Pidgeon Ireland 29 635 0.8× 1.0k 1.7× 541 1.0× 456 0.9× 110 0.2× 65 2.7k
Craig Eagle United States 13 536 0.7× 254 0.4× 749 1.4× 268 0.5× 240 0.5× 26 1.6k
Michelle Wilson United Kingdom 5 839 1.0× 455 0.7× 942 1.8× 357 0.7× 170 0.3× 7 2.4k
Atsushi Tatsuguchi Japan 23 339 0.4× 461 0.8× 479 0.9× 822 1.6× 137 0.3× 95 2.0k
R J Coffey United States 14 866 1.1× 1.0k 1.7× 1.6k 3.0× 491 1.0× 258 0.5× 15 3.1k
Vincent C. Daniel United States 14 631 0.8× 1.3k 2.2× 314 0.6× 497 1.0× 93 0.2× 23 2.8k

Countries citing papers authored by Elizabeth Half

Since Specialization
Citations

This map shows the geographic impact of Elizabeth Half's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Half with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Half more than expected).

Fields of papers citing papers by Elizabeth Half

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Half. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Half. The network helps show where Elizabeth Half may publish in the future.

Co-authorship network of co-authors of Elizabeth Half

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Half. A scholar is included among the top collaborators of Elizabeth Half based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Half. Elizabeth Half is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Golan, Maya Aharoni, Lior H. Katz, Ido Laish, et al.. (2025). Raising the Age for Starting Colonoscopy to 35 Years for Individuals With path_MSH6 Carriers May Lead to Missed Opportunities for Detecting Advanced Neoplasia in a Notable Percentage of Carriers. The American Journal of Gastroenterology. 121(1). 205–211. 2 indexed citations
2.
Half, Elizabeth, Zohar Levi, Ajitha Mannalithara, et al.. (2024). Colorectal cancer screening at age 45 years in Israel: Cost‐effectiveness and global implications. Cancer. 130(6). 901–912. 2 indexed citations
3.
Ben‐Aharon, Irit, Ran S. Rotem, Cheli Melzer Cohen, et al.. (2023). Pharmaceutical Agents as Potential Drivers in the Development of Early-Onset Colorectal Cancer: Case-Control Study. JMIR Public Health and Surveillance. 9. e50110–e50110. 4 indexed citations
4.
Goldberg, Yael, Hanna Segev, Itay Maza, et al.. (2023). High prevalence of MUTYH associated polyposis among minority populations in Israel, due to rare founder pathogenic variants. Digestive and Liver Disease. 55(7). 880–887.
5.
Maza, Itay, et al.. (2023). Gut microbial signatures are associated with Lynch syndrome (LS) and cancer history in Druze communities in Israel. Scientific Reports. 13(1). 20677–20677. 2 indexed citations
6.
Katz, Lior H., Rachel Gingold‐Belfer, Ido Laish, et al.. (2022). Phenotypic diversity among juvenile polyposis syndrome patients from different ethnic background. Hereditary Cancer in Clinical Practice. 20(1). 2–2. 4 indexed citations
7.
Abu‐Freha, Naim, Lior H. Katz, Revital Kariv, et al.. (2021). Post‐polypectomy surveillance colonoscopy: Comparison of the updated guidelines. United European Gastroenterology Journal. 9(6). 681–687. 16 indexed citations
8.
Laish, Ido, Eitan Friedman, Inbal Kedar, et al.. (2021). Double heterozygotes of BRCA1/BRCA2 and mismatch repair gene pathogenic variants: case series and clinical implications. Breast Cancer Research and Treatment. 188(3). 685–694. 8 indexed citations
9.
Lachter, Jesse, et al.. (2018). Screening to Detect Precursor Lesions of Pancreatic Adenocarcinoma in High-risk Individuals: A Single-center Experience. Rambam Maimonides Medical Journal. 9(4). e0029–e0029. 11 indexed citations
10.
Half, Elizabeth, et al.. (2017). Update on Screening for Urological Malignancies. Rambam Maimonides Medical Journal. 8(4). e0041–e0041. 7 indexed citations
11.
Lieberman, Sari, Tom Walsh, Tomer Adar, et al.. (2017). Features of Patients With Hereditary Mixed Polyposis Syndrome Caused by Duplication of GREM1 and Implications for Screening and Surveillance. Gastroenterology. 152(8). 1876–1880.e1. 25 indexed citations
12.
Half, Elizabeth, Nirit Keren, Tatiana Dorfman, et al.. (2015). P-165 Specific changes in fecal microbiota may differentiate Pancreatic Cancer patients from healthy individuals. Annals of Oncology. 26. iv48–iv48. 11 indexed citations
13.
Lynch, Patrick M., Carol A. Burke, Robin Phillips, et al.. (2015). An international randomised trial of celecoxib versus celecoxib plus difluoromethylornithine in patients with familial adenomatous polyposis. Gut. 65(2). 286–295. 75 indexed citations
14.
Half, Elizabeth & Nadir Arber. (2013). Chemoprevention of Gastrointestinal Neoplasia. Current Gastroenterology Reports. 15(5). 320–320. 5 indexed citations
15.
Half, Elizabeth, Liat Mlynarsky, Timna Naftali, Fabiana Benjaminov, & Fred M. Konikoff. (2013). False Negative Fecal Occult Blood Test May Be Associated with Increased Mortality from Colorectal Cancer. Digestive Diseases and Sciences. 58(9). 2639–2645. 4 indexed citations
16.
Lynch, Patrick M., Gregory D. Ayers, Ellen Richmond, et al.. (2010). The Safety and Efficacy of Celecoxib in Children With Familial Adenomatous Polyposis. The American Journal of Gastroenterology. 105(6). 1437–1443. 57 indexed citations
17.
Half, Elizabeth & Nadir Arber. (2009). Colon cancer: preventive agents and the present status of chemoprevention. Expert Opinion on Pharmacotherapy. 10(2). 211–219. 123 indexed citations
18.
Half, Elizabeth & Robert S. Bresalier. (2003). Clinical management of hereditary colorectal cancer syndromes. Current Opinion in Gastroenterology. 20(1). 32–42. 18 indexed citations
19.
Half, Elizabeth, Russell R. Broaddus, Kathleen D. Danenberg, et al.. (2003). HER‐2 receptor expression, localization, and activation in colorectal cancer cell lines and human tumors. International Journal of Cancer. 108(4). 540–548. 70 indexed citations
20.
Half, Elizabeth, et al.. (2002). Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ.. PubMed. 62(6). 1676–81. 288 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gideon Steinbach Breakdown of academic impact, for papers by Roberto Mazzanti Breakdown of academic impact, for papers by Russell F. Jacoby Breakdown of academic impact, for papers by Lee J. Hixson Breakdown of academic impact, for papers by Graham P. Pidgeon Breakdown of academic impact, for papers by Craig Eagle Breakdown of academic impact, for papers by Michelle Wilson Breakdown of academic impact, for papers by Atsushi Tatsuguchi Breakdown of academic impact, for papers by R J Coffey Breakdown of academic impact, for papers by Vincent C. Daniel
Rankless by CCL
2026